Biochemist Engineer by training with a PhD in molecular and cellular genetics, I have over 25 years of experience in biopharmaceutical development and manufacturing, from early to late stages I have built deep expertise in process development, scale-up, manufacturing, validation, and CMC strategies aligned with global regulatory standards. I have held senior roles across pharma, biotech, and CDMO environments—including Merck and Novasep—leading cross-functional teams and managing global CDMO partnerships.

I have contributed to the advancement of monoclonal antibodies and gene therapies, implementing innovative solutions and driving the adoption of technologies such as continuous bioprocessing. With a strong commitment to scientific excellence and operational rigor, I focus on delivering robust, scalable, and compliant manufacturing strategies to accelerate the development of complex biologics and advanced therapies.